(1)
Reasons of Treatment Switching from First Generation to Second and Third Generations of TKIs Among CML Patients in Iraq -Kurdistan Region from 2014-2024. JOC 2025, 24 (8s), 360-368. https://doi.org/10.64149/J.Carcinog.24.8s.360-368.